Lucid Psycheceuticals Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 2

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Lucid Psycheceuticals General Information

Description

Developer of novel therapeutics intended to cure mental health disorders. The company offers specialty psychedelic pharmaceutical therapies to treat critical neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and multiple sclerosis along with depression, anxiety, dementia and similar other conditions, enabling patients to lead healthier lives.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 243 College Street
  • Suite 101
  • Toronto, Ontario M5R 1T5
  • Canada
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Parent Company
Corporate Office
  • 243 College Street
  • Suite 101
  • Toronto, Ontario M5R 1T5
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lucid Psycheceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Lucid Psycheceuticals‘s full profile, request access.

Request a free trial

Lucid Psycheceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel therapeutics intended to cure mental health disorders. The company offers specialty psychedelic pharm
Drug Discovery
Toronto, Canada
2 As of 2021

San Diego, CA
 

Redwood City, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lucid Psycheceuticals Competitors (45)

One of Lucid Psycheceuticals’s 45 competitors is ACADIA Pharmaceuticals, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ACADIA Pharmaceuticals Formerly VC-backed San Diego, CA
XWPharma Venture Capital-Backed Redwood City, CA
Retrotope Formerly VC-backed Los Altos, CA
NeuroNascent Venture Capital-Backed Clarksville, MD
CervoMed Formerly VC-backed Boston, MA
You’re viewing 5 of 45 competitors. Get the full list »

Lucid Psycheceuticals Patents

Lucid Psycheceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4788357-A1 Peptidyl arginine deiminase (pad) inhibitors and methods of using the same Pending 02-Oct-2023
WO-2025074194-A1 Peptidyl arginine deiminase (pad) inhibitors and methods of using the same Inactive 02-Oct-2023
US-20260294917-A1 Ingestible formulations comprising methylliberine and one or more sugars and their use to treat the adverse effects of alcohol consumption Pending 24-Apr-2023
WO-2024224285-A1 Ingestible formulations comprising methylliberine and one or more sugars and their use to treat the adverse effects of alcohol consumption Inactive 24-Apr-2023 A61P25/32

Lucid Psycheceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lucid Psycheceuticals FAQs

  • When was Lucid Psycheceuticals founded?

    Lucid Psycheceuticals was founded in 2020.

  • Where is Lucid Psycheceuticals headquartered?

    Lucid Psycheceuticals is headquartered in Toronto, Canada.

  • What is the size of Lucid Psycheceuticals?

    Lucid Psycheceuticals has 2 total employees.

  • What industry is Lucid Psycheceuticals in?

    Lucid Psycheceuticals’s primary industry is Drug Discovery.

  • Is Lucid Psycheceuticals a private or public company?

    Lucid Psycheceuticals is a Private company.

  • What is the current valuation of Lucid Psycheceuticals?

    The current valuation of Lucid Psycheceuticals is .

  • What is Lucid Psycheceuticals’s current revenue?

    The current revenue for Lucid Psycheceuticals is .

  • Who are Lucid Psycheceuticals’s competitors?

    ACADIA Pharmaceuticals, XWPharma, Retrotope, NeuroNascent, and CervoMed are some of the 45 competitors of Lucid Psycheceuticals.

  • When was Lucid Psycheceuticals acquired?

    Lucid Psycheceuticals was acquired on 21-Sep-2021.

  • Who acquired Lucid Psycheceuticals?

    Lucid Psycheceuticals was acquired by Quantum BioPharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process